Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
PBMs Under Fire Again, But Despite Bipartisan Pressure Reforms May Be Elusive
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
What Are PBMs? Chuck Grassley Presses RFK Jr. On Accountability For Pharmacy Benefit Managers At Confirmation Hearing
President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...
Modern Healthcare5h
Cigna plans to limit out-of-pocket drug costs for patients
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
Five takeaways from the first week of Arkansas 95th General Assembly
The 95th General Assembly of the Arkansas Legislature opened this week and began doing its business of the people.
RealClearMarkets6d
Diagnosing the Problem With PBMs' Incentives
Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...
MedPage Today14d
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in revenue from 2017 to 2022, ...
Drug Store News5d
NACDS explains PBMs in latest video
The National Association of Chain Drug Stores released a video that explains how PBMs operate and how states and Congress are ...
MedCity News13d
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...